Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Middleton

Showing results (321-330 of 348) with videos related to

Pageof 35
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 30, 2018
Acetyl-CoA Carboxylase Inhibitor GS-0976 for 12 Weeks Reduces Hepatic De Novo Lipogenesis and Steatosis in Patients With Nonalcoholic SteatohepatitisEric J Lawitz, Angie Coste, Fred Poordad, et al.
JAMA|January 23, 2019
Effect of a Low Free Sugar Diet vs Usual Diet on Nonalcoholic Fatty Liver Disease in Adolescent Boys: A Randomized Clinical TrialJeffrey B Schwimmer, Patricia Ugalde-Nicalo, Jean A Welsh, et al.
Magnetic Resonance in Medicine|February 10, 2021
Temperature-corrected proton density fat fraction estimation using chemical shift-encoded MRI in phantomsRuvini Navaratna, Ruiyang Zhao, Timothy J Colgan, et al.
Radiology|January 19, 2021
Linearity and Bias of Proton Density Fat Fraction as a Quantitative Imaging Biomarker: A Multicenter, Multiplatform, Multivendor Phantom StudyHouchun H Hu, Takeshi Yokoo, Mustafa R Bashir, et al.
Radiology|October 10, 2023
Repeatability of MRI Biomarkers in Nonalcoholic Fatty Liver Disease: The NIMBLE ConsortiumKathryn J Fowler, Sudhakar K Venkatesh, Nancy Obuchowski, et al.
Journal of Medicinal Chemistry|December 7, 2010
An imidazopiperidine series of CCR5 antagonists for the treatment of HIV: the discovery of N-{(1S)-1-(3-fluorophenyl)-3-[(3-endo)-3-(5-isobutyryl-2-methyl-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridin-1-yl)-8-azabicyclo[3.2.1]oct-8-yl]propyl}acetamide (PF-232798)Paul A Stupple, David V Batchelor, Martin Corless, et al.
European Radiology|April 26, 2021
Magnetic resonance elastography biomarkers for detection of histologic alterations in nonalcoholic fatty liver disease in the absence of fibrosisYali Qu, Michael S Middleton, Rohit Loomba, et al.
Journal of Hepatology|November 11, 2022
Changes in abdominal adipose tissue depots assessed by MRI correlate with hepatic histologic improvement in non-alcoholic steatohepatitisWei Shen, Michael S Middleton, Guilherme M Cunha, et al.
Environmental Geochemistry and Health|January 19, 2022
Editorial: The society for environmental geochemistry and health (SEGH): 50 years and beyondM J Watts, A Argyraki, M Barbieri, et al.
Journal of Hepatology|July 5, 2014
Sebelipase alfa over 52 weeks reduces serum transaminases, liver volume and improves serum lipids in patients with lysosomal acid lipase deficiencyVassili Valayannopoulos, Vera Malinova, Tomas Honzík, et al.
Pageof 35

Showing results (321-330 of 348) with videos related to

Sort By:
Pageof 35
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 30, 2018
Acetyl-CoA Carboxylase Inhibitor GS-0976 for 12 Weeks Reduces Hepatic De Novo Lipogenesis and Steatosis in Patients With Nonalcoholic SteatohepatitisEric J Lawitz, Angie Coste, Fred Poordad, et al.
JAMA|January 23, 2019
Effect of a Low Free Sugar Diet vs Usual Diet on Nonalcoholic Fatty Liver Disease in Adolescent Boys: A Randomized Clinical TrialJeffrey B Schwimmer, Patricia Ugalde-Nicalo, Jean A Welsh, et al.
Magnetic Resonance in Medicine|February 10, 2021
Temperature-corrected proton density fat fraction estimation using chemical shift-encoded MRI in phantomsRuvini Navaratna, Ruiyang Zhao, Timothy J Colgan, et al.
Radiology|January 19, 2021
Linearity and Bias of Proton Density Fat Fraction as a Quantitative Imaging Biomarker: A Multicenter, Multiplatform, Multivendor Phantom StudyHouchun H Hu, Takeshi Yokoo, Mustafa R Bashir, et al.
Radiology|October 10, 2023
Repeatability of MRI Biomarkers in Nonalcoholic Fatty Liver Disease: The NIMBLE ConsortiumKathryn J Fowler, Sudhakar K Venkatesh, Nancy Obuchowski, et al.
Journal of Medicinal Chemistry|December 7, 2010
An imidazopiperidine series of CCR5 antagonists for the treatment of HIV: the discovery of N-{(1S)-1-(3-fluorophenyl)-3-[(3-endo)-3-(5-isobutyryl-2-methyl-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridin-1-yl)-8-azabicyclo[3.2.1]oct-8-yl]propyl}acetamide (PF-232798)Paul A Stupple, David V Batchelor, Martin Corless, et al.
European Radiology|April 26, 2021
Magnetic resonance elastography biomarkers for detection of histologic alterations in nonalcoholic fatty liver disease in the absence of fibrosisYali Qu, Michael S Middleton, Rohit Loomba, et al.
Journal of Hepatology|November 11, 2022
Changes in abdominal adipose tissue depots assessed by MRI correlate with hepatic histologic improvement in non-alcoholic steatohepatitisWei Shen, Michael S Middleton, Guilherme M Cunha, et al.
Environmental Geochemistry and Health|January 19, 2022
Editorial: The society for environmental geochemistry and health (SEGH): 50 years and beyondM J Watts, A Argyraki, M Barbieri, et al.
Journal of Hepatology|July 5, 2014
Sebelipase alfa over 52 weeks reduces serum transaminases, liver volume and improves serum lipids in patients with lysosomal acid lipase deficiencyVassili Valayannopoulos, Vera Malinova, Tomas Honzík, et al.
Pageof 35